NCT04976894Active, not recruiting
Korean Stroke Cohort for Functioning and Rehabilitation-II
Source: ClinicalTrials.gov · Last updated 28 Apr 2026
Brief summary (registry, in English)
Korean Stroke Cohort for functioning and rehabilitation (KOSCO)-II is a large, multi-centre prospective cohort study for all acute first-ever stroke patients admitted to participating hospitals in nine distinct areas of Korea. This study is designed as a 10-year, longitudinal follow-up investigating the residual disabilities, activity limitations, and quality of life issues arising in patients suffering from first-ever stroke as previous similar stroke cohort with KOSCO. The main objectives of this study are to identify and compare the factors that influence residual disability and long-term quality of life in first-ever acute stroke patients with KOSCO. The secondary objectives of this study are to determine and compare the risk of mortality and recurrent vascular events in first-ever acute stroke patients with KOSCO. Investigators will investigate longitudinal health behaviors and patterns of healthcare utilization, including stroke rehabilitation care. Investigators will also investigate the long-term health status, mood, and quality of life in stroke patient caregivers. In addition, investigators will identify baseline and ongoing characteristics that are associated with secondary outcomes.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 2431 (actual)
- First submitted
- 16 Jul 2021
- Start date
- 1 Jan 2020
- Primary completion date
- 31 Dec 2030
- Lead sponsor
- Samsung Medical Center
- Diseases
- Stroke
- NCT number
- NCT04976894
What you commit to
- Study type: Observational
- Participants enrolled: 2431
- From 1 Jan 2020 to the primary completion date, 31 Dec 2030
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- History of stroke.
- Traumatic intracerebral hemorrhage.
Other
- Transient ischemic attack.
- Not Korean.
Who the study is looking for
- First-ever acute stroke (ischemic stroke or intracerebral hemorrhage) with corresponding lesion and/or evidence of acute arterial occlusion on CT (A)- or MRI/A-scan.
- Age ≥ 19 years at onset of stroke.
- Onset of symptoms within seven days prior to inclusion.
Age in the registry: 19 years to - · Sex: All
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Samsung Medical Center Coordinator of this site? Confirm its status | Seoul | South Korea | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.